Record year comes as the rise of precision medicine drives a surge in demandPHILADELPHIA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, more than doubled its growth in 2024. The company enters 2025 having cemented its leadership position, with life sciences organizations and diagnostic laboratories increasingly deploying its Concentriq® enterprise pathology platform to advance the next novel therapies and diagnostics. “2024 was a breako ...